StemSave is once again sponsoring the International Conference on Dental and Craniofacial Stem Cells [ICDCSC]. This is the 3rd conference since the inaugural conference of 2012 and will be held on October 26-28 in Paris, France. The conference will be co-chaired by Dr. Jeremy Mao of Columbia University [StemSave’s Chief Scientific Advisor] and Dr. Michael Goldberg of University Paris Descartes. They will be joined by 30 internationally renowned speakers in a collegial and conducive atmosphere to catalyze the biology of stem cell research and translational advances towards therapeutics.
In a newly published article by the Wall Street Journal, a team of Columbia and Cornell researchers led by Dr. Jeremy Mao [a member of StemSave’s Scientific Advisory Council] has developed a potential method to treat patients with torn menisci. The method involves 3D-printing a biodegradable scaffold of the meniscus, infusing it with growth factors, and implanting it into the knee. Once in the patient’s body, the growth factors should attract autologous [the patient’s own] stem cells to generate a new, natural meniscus.
Dr. Mao’s lecture focused on a variety of insights on the science, technology, and medical impact of stem cells and regenerative medicine including one of the overarching goals of stem cell researchers;reducing the health care expenditure in the US while delivering therapies and treatments that will lead to longer, healthier lives.
Dr. Jeremy Mao, StemSave’s Chief Science Advisor presented at the American Association for Dental Research (AADR) Annual Meeting in Tampa, FL this past week.
Dr Mao, DDS, PhD, a leading stem cell researcher and co-head of Columbia University's Center for Craniofacial Regeneration, discussed several recent advances in stem cell dental treatments and the likely impact stem cells will have on the practice of dentistry.